Global Animal Biotechnology Market Overview
As per MRFR analysis, the Animal Biotechnology Market Size was estimated at 14.33 (USD Billion) in 2022. The Animal Biotechnology Market is expected to grow from 15.84 (USD Billion) in 2023 to 39.1 (USD Billion) by 2032. The Animal Biotechnology Market CAGR (growth rate) is expected to be around 10.56% during the forecast period (2024 - 2032).
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Key Animal Biotechnology Market Trends Highlighted
The animal biotechnology market is witnessing significant growth due to technological advancements in molecular biology and genomics. The development of advanced techniques like gene editing and gene therapy holds immense potential for improving animal health and productivity.
Furthermore, concerns over food safety and the growing demand for animal-based protein are driving the adoption of genetically modified animals, vaccines, and diagnostics.
Additionally, the emergence of precision livestock farming practices is creating opportunities for data-driven decision-making and improved animal management.
The market is anticipated to continue expanding as scientific breakthroughs and regulatory approvals open new possibilities in animal biotechnology.
Animal Biotechnology Market Drivers
Rising Demand for Animal-derived Products
A significant factor that contributes to the growth of the animal biotechnology market is the increase in the population. The substantial increase in the population results in more people who need to be fed with animal-based products such as meat, milk, and eggs.
Notably, with high levels of population growth, there is also a need to grow more food to meet the increasing consumption levels.
In that light, the overall increase in the demand for animal food products corresponds with an increase in animal biotechnological solutions that provide more effective ways to breed, nurture, and control diseases in animals.
Advancements in Genetic Engineering
Advancements in genetic engineering techniques, such as CRISPR-Cas9 and gene editing, have revolutionized the field of animal biotechnology. These technologies allow scientists to make precise changes to the genetic makeup of animals, leading to the development of animals with desirable traits.
For instance, genetic engineering can be used to enhance disease resistance, improve growth rates, or modify the nutritional value of animal products. As these technologies continue to advance, they are expected to further drive the growth of the animal biotechnology market.
Government Initiatives and Support
Many governments are supporting the growth of animal biotechnology by offering funding and other forms of support for research and development as well as the application of animal biotechnology.
Such reforms by government agencies offer a companionable environment for the growth and development of the Animal Biotechnology Market.
Animal Biotechnology Market Segment Insights
Animal Biotechnology Market Product Type Insights
The Animal Biotechnology Market is segmented by product type into cloning services, embryo biotechnology, gene editing, in vitro fertilization, and marker assisted selection. Gene editing is expected to grow at the highest rate in the animal biotechnology market over the forecast period, due to a high adoption rate in animal breeding and research.
Cloning services increase the number of genetically identical cloned animals, usually for research or conservation. This provides all cloned animals with the same DNA.
This segment will grow steadily throughout the forecast period, and the demand for cloned animals in biomedical research and the development of new cloning techniques will be vital.
The manipulation of a part of or the whole embryo to improve specific animal traits such as growth rate, resistance to diseases and fertility is referred to as embryo biotechnology. This segment will grow slowly during the forecast period due to ethics and regulatory issues.
Gene editing, also known as genome editing, refers to the use of technologies to make precise changes to an animal’s DNA. The gene editing segment will grow significantly during the forecast period, given potential applications in animal breeding, disease management, and research in the creation of new animal models.
The IVF segment refers to the technique of fertilizing an egg outside the body to produce the technique needed. The growing demand for IVF in animal breeding and the introduction of new IVF techniques will support the continued growth of this segment throughout the forecast period.
The MAS segment will grow slightly during the forecast period, as the availability of genetic markers and the cost of MAS testing is a major challenge.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Animal Biotechnology Market Application Insights
The Animal Biotechnology Market segmentation by Application includes Livestock Production, Pet Care, Veterinary Diagnostics, Xenotransplantation, and Wildlife Conservation. The Livestock Production segment is expected to dominate the market with a significant market share due to the growing demand for animal-derived products such as meat, milk, and eggs.
The Pet Care segment is also expected to grow steadily due to the increasing pet ownership and spending on pet healthcare. Veterinary Diagnostics holds a considerable market share owing to the rising prevalence of animal diseases and the need for accurate and rapid diagnostics.
Xenotransplantation and Wildlife Conservation segments are relatively smaller but are expected to gain traction in the coming years due to advancements in biotechnology and the need for organ transplantation and wildlife conservation efforts.
Animal Biotechnology Market Technology Insights
CRISPR-Cas9, gene transfer, genome editing, nanotechnology, and RNA interference are prominent technologies driving the growth of the Animal Biotechnology Market. CRISPR-Cas9 technology offers precise genome editing capabilities, enabling scientists to modify genes with high accuracy.
Gene transfer involves introducing foreign genes into animal cells to alter their genetic makeup and enhance desirable traits. Genome editing techniques allow researchers to make targeted changes to DNA, facilitating the development of disease-resistant and improved livestock breeds.
Nanotechnology finds application in animal biotechnology for drug delivery, disease diagnostics, and tissue engineering. RNA interference technology enables the regulation of gene expression, providing a powerful tool for studying gene function and developing therapeutics.
The Animal Biotechnology Market segmentation by technology helps stakeholders identify specific growth opportunities and develop targeted strategies to capitalize on the advancements in these technologies.
Animal Biotechnology Market Animal Type Insights
The Animal Biotechnology Market is segmented by animal type into Cattle, Poultry, Pets (Dogs and Cats), Horses, and Other Animals (Pigs, Sheep, etc.). Among these segments, the Cattle segment held the largest market share in 2023, owing to the increasing demand for animal biotechnology products for cattle breeding and disease prevention.
The Poultry segment is also expected to witness significant growth in the coming years, driven by the rising demand for poultry products and the need for efficient disease management practices.
The Pets (Dogs and Cats) segment is expected to grow steadily, driven by the increasing adoption of pets and the growing awareness of pet health and well-being. The horse segment is also expected to experience growth, driven by the demand for biotechnology products for horse breeding and performance enhancement.
The Other Animals (Pigs, Sheep, etc.) segment is expected to witness moderate growth, driven by the growing demand for animal biotechnology products for disease prevention and productivity improvement.
Overall, the Animal Type segment of the Animal Biotechnology Market is expected to witness significant growth in the coming years, driven by the increasing demand for animal biotechnology products across various animal types.
Animal Biotechnology Market Regional Insights
The Animal Biotechnology Market is segmented into North America, Europe, APAC, South America, and MEA. North America dominated the market in 2023 with a revenue of USD 5.24 billion, owing to the presence of major market players, advanced research infrastructure, and high adoption of animal biotechnology in the region.
Europe is expected to witness significant growth during the forecast period, driven by government initiatives to promote animal health and welfare and rising demand for animal-derived products.
APAC is projected to be the fastest-growing region, with a CAGR of 12.5% during the forecast period, due to increasing investments in animal biotechnology research and development and growing demand for animal-derived products in the region.
South America and MEA are expected to experience moderate growth, owing to the increasing adoption of animal biotechnology in livestock production and rising awareness about animal health and welfare.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Animal Biotechnology Market Key Players and Competitive Insights:
Major players in the Animal Biotechnology Market are constantly striving to gain a competitive edge by investing in research and development, expanding their product portfolios, and forming strategic partnerships.
Leading Animal Biotechnology Market players are actively involved in developing innovative technologies, such as gene editing and reproductive technologies, to meet the growing demand for improved animal health and productivity.
The Animal Biotechnology Market development is driven by factors such as increasing demand for animal-derived products, rising concerns about animal welfare, and advancements in genetic engineering techniques.
Animal Biotechnology Market Competitive Landscape is characterized by the presence of both established and emerging players, with each company focusing on specific areas of expertise to differentiate themselves in the market.
A leading company in the Animal Biotechnology Market is Zoetis, which offers a wide range of products and services for animal health and nutrition. Zoetis has a strong focus on research and development, with a dedicated team of scientists working on developing innovative solutions for animal care.
The company's product portfolio includes vaccines, antibiotics, parasiticides, and other treatments for various animal species. Zoetis has a presence, with operations in over 100 countries and a strong distribution network. The company's commitment to animal health and well-being has made it a trusted partner for veterinarians and animal owners worldwide.
A competitor company in the Animal Biotechnology Market is Merck Animal Health, which is also a major player in the industry. Merck Animal Health offers a comprehensive range of products, including vaccines, pharmaceuticals, and other solutions for animal health.
The company has a strong focus on innovation, with a dedicated research and development team working on developing new and improved products. Merck Animal Health has a presence, with operations in over 150 countries and a strong distribution network.
The company's commitment to animal health and well-being has made it a trusted partner for veterinarians and animal owners worldwide. Merck Animal Health's competitive strategies include investing in research and development, expanding its product portfolio, and forming strategic partnerships to gain a competitive edge in the market.
Key Companies in the Animal Biotechnology Market Include:
- Illumina
- NEOGEN Corporation
- QIAGEN
- PerkinElmer
- Pacific Biosciences of California
- Eurofins Scientific
- Boehringer Ingelheim Animal Health
- BioRad Laboratories
- Bayer Animal Health
- Zoetis
- Danaher Corporation
- Agilent Technologies
- Thermo Fisher Scientific
- Elanco Animal Health
- Oxford Nanopore Technologies
- Merck
Animal Biotechnology Market Developments
Several factors contribute to this growth, including rising demand for animal-derived products, advancements in gene editing technologies, and increasing government support for animal biotechnology research.
Recent developments in the market include the emergence of gene editing tools such as CRISPR-Cas9, which enable precise modifications to animal genomes. This technology holds significant potential for improving animal health, productivity, and welfare.
Additionally, companies are investing in developing novel vaccines and therapeutics for animal diseases, driven by the increasing prevalence of zoonotic diseases and the need to ensure food safety.
Animal Biotechnology Market Segmentation
Animal Biotechnology Market Segmentation Insights
- Animal Biotechnology Market Product Type Outlook
- Cloning Services
- Embryo Biotechnology
- Gene Editing
- In Vitro Fertilization (IVF)
- Marker Assisted Selection (MAS)
Animal Biotechnology Market Application Outlook
- Livestock Production
- Pet Care
- Veterinary Diagnostics
- Xenotransplantation
- Wildlife Conservation
Animal Biotechnology Market Technology Outlook
- CRISPR-Cas9
- Gene Transfer
- Genome Editing
- Nanotechnology
- RNA Interference
Animal Biotechnology Market Animal Type Outlook
- Cattle
- Poultry
- Pets (Dogs and Cats)
- Horses
- Other Animals (Pigs, Sheep, etc.)
Animal Biotechnology Market Regional Outlook
- North America
- Europe
- South America
- Asia-Pacific
- Middle East and Africa
Animal Biotechnology Market Report Scope
|
Report Attribute/Metric
|
Details
|
|
Market Size 2022
|
14.33(USD Billion)
|
|
Market Size 2023
|
15.84(USD Billion)
|
|
Market Size 2032
|
39.1(USD Billion)
|
|
Compound Annual Growth Rate (CAGR)
|
10.56% (2024 - 2032)
|
|
Report Coverage
|
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
|
Base Year
|
2023
|
|
Market Forecast Period
|
2024 - 2032
|
|
Historical Data
|
2019 - 2023
|
|
Market Forecast Units
|
USD Billion
|
|
Key Companies Profiled
|
Illumina, NEOGEN Corporation, QIAGEN, PerkinElmer, Pacific Biosciences of California, Eurofins Scientific, Boehringer Ingelheim Animal Health, BioRad Laboratories, Bayer Animal Health, Zoetis, Danaher Corporation, Agilent Technologies, Thermo Fisher Scientific, Elanco Animal Health, Oxford Nanopore Technologies, Merck
|
|
Segments Covered
|
Product Type, Application, Technology, Animal Type, Regional
|
|
Key Market Opportunities
|
1 Gene editing for disease resistance
2 Enhanced nutrition and feed efficiency
3 Precision breeding for desirable traits
4 Diagnostics and personalized treatments
5 Animal welfare and sustainable practices
|
|
Key Market Dynamics
|
Rising demand for animal protein
Technological advancements in genetic engineering
Increasing prevalence of animal diseases
Growing awareness of animal welfare
Expansion of the pet industry
|
|
Countries Covered
|
North America, Europe, APAC, South America, MEA
|
Â
Â
Frequently Asked Questions (FAQ) :
The Animal Biotechnology market was valued at USD 15.84 billion in 2023 and is expected to reach USD 39.1 billion by 2032, exhibiting a CAGR of 10.56% during the forecast period.
North America is expected to dominate the Animal Biotechnology market throughout the forecast period due to the presence of major market players, advanced research infrastructure, and increasing adoption of animal biotechnology in livestock production.
The major growth drivers of the Animal Biotechnology market include the rising demand for animal-derived products, increasing prevalence of animal diseases, growing adoption of precision livestock farming, and technological advancements in gene editing and reproductive technologies.
Animal Biotechnology finds applications in various sectors, including livestock breeding and genetics, veterinary diagnostics and therapeutics, animal nutrition and health management, and production of biopharmaceuticals and vaccines.
Some of the prominent players in the Animal Biotechnology market are Thermo Fisher Scientific, Merck & Co., Inc., Zoetis, Inc., Bayer AG, and Neogen Corporation.
The Animal Biotechnology market faces certain challenges, such as ethical concerns regarding genetic modification, regulatory hurdles, and potential risks associated with the use of genetically modified animals.
Emerging trends in the Animal Biotechnology market include the integration of artificial intelligence, machine learning, and big data analytics in animal breeding and health management, as well as the development of personalized and targeted therapies for animal diseases.
The COVID-19 pandemic had a significant impact on the Animal Biotechnology market, disrupting supply chains and affecting research and development activities. However, the market is expected to recover and continue its growth trajectory in the post-pandemic period.
Regulatory considerations for Animal Biotechnology products vary across different regions. Key regulatory bodies include the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and the World Organisation for Animal Health (OIE).
Animal Biotechnology raises ethical concerns related to animal welfare, environmental impact, and potential unintended consequences of genetic modifications. Ongoing debates and discussions address the responsible use and regulation of Animal Biotechnology.
